ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report) saw a large decrease in short interest in December. As of December 15th, there was short interest totalling 3,900 shares, a decrease of 7.1% from the November 30th total of 4,200 shares. Based on an average daily volume of 12,300 shares, the short-interest ratio is currently 0.3 days.
Hedge Funds Weigh In On ProShares Ultra Nasdaq Biotechnology
An institutional investor recently raised its position in ProShares Ultra Nasdaq Biotechnology stock. Jane Street Group LLC raised its stake in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Free Report) by 8.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,803 shares of the exchange traded fund’s stock after purchasing an additional 374 shares during the quarter. Jane Street Group LLC owned about 0.35% of ProShares Ultra Nasdaq Biotechnology worth $306,000 at the end of the most recent quarter.
ProShares Ultra Nasdaq Biotechnology Stock Down 3.3 %
NASDAQ BIB traded down $1.73 during mid-day trading on Monday, reaching $50.10. 16,934 shares of the stock were exchanged, compared to its average volume of 22,108. ProShares Ultra Nasdaq Biotechnology has a 1-year low of $47.19 and a 1-year high of $69.56. The business’s fifty day simple moving average is $58.40 and its 200 day simple moving average is $61.75.
ProShares Ultra Nasdaq Biotechnology Increases Dividend
About ProShares Ultra Nasdaq Biotechnology
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.
Featured Articles
- Five stocks we like better than ProShares Ultra Nasdaq Biotechnology
- Manufacturing Stocks Investing
- 3 Must-Hold Stocks with Double-Digit Upside for 2025
- The Basics of Support and Resistance
- Micron: Why Now Is the Time to Be Brave
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 3 Stocks That Wall Street Insiders Can’t Stop Buying
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.